Management of women with high grade CIN/CGIN on initial biopsy (N = 50)

Treatment

Number (%)

LLETZ

Active surveillance

Care transferred to another provider

Patient did not attend for follow-up

40 (80.0)

7 (14.0)

2 (4.0)

1 (2.0)

Histology results from LLETZ samples (N = 40)

Result

Number (%)

No residual CIN

CIN 1

CIN 2

CIN 3

Ungraded CIN

High grade CGIN

Adenocarcinoma

1 (2.5)

9 (22.5)

15 (37.5)

10 (25.0)

3 (7.5)

1 (2.5)

1 (2.5)